CARDIFF ONCOLOGY, INC. Operating Leases, Future Minimum Payments, Due in Four Years
CARDIFF ONCOLOGY, INC. (CRDF) had Operating Leases, Future Minimum Payments, Due in Four Years of $5.87 thousand as of 2018-12-31, per its 10-K filed 2020-02-27.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFourYears · last filed 2020-02-27
- 2018-12-31: Operating Leases, Future Minimum Payments, Due in Four Years $5.87K.
- 2017-12-31: Operating Leases, Future Minimum Payments, Due in Four Years $959.40K.
- 2016-12-31: Operating Leases, Future Minimum Payments, Due in Four Years $931.46K.
- 2015-12-31: Operating Leases, Future Minimum Payments, Due in Four Years $796.72K.
| Period end | Operating Leases, Future Minimum Payments, Due in Four Years |
|---|---|
| 2018-12-31 | $5.87K 10-K · filed 2020-02-27 |
| 2017-12-31 | $959.40K 10-K · filed 2018-02-26 |
| 2016-12-31 | $931.46K 10-K · filed 2017-03-15 |
| 2015-12-31 | $796.72K 10-K · filed 2016-03-10 |
| 2014-12-31 | $6.38K 10-K · filed 2015-03-12 |
| 2013-12-31 | $250.85K 10-K · filed 2014-03-17 |
| 2012-12-31 | $233.51K 10-K · filed 2013-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B |